Aqueous-mediated ring opening of epoxides with oximes: A rapid entry into β-hydroxy oxime O-ethers as potential β-adrenergic blocking agents

Synthesis

Volumn , Issue 13, 2008, Pages 2055-2064

  Rad, Mohammad Navid Soltani ^a   Behrouz, Somayeh ^a   Dianat, Manije ^b  

^a SHIRAZ UNIVERSITY OF TECHNOLOGY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Aqueous media; Epoxides; O alkylations; Oximes; Ring opening

Indexed keywords

ETHERS;

BLOCKING AGENTS; RING-OPENING;

ORGANIC COMPOUNDS;

1 (4 BROMOPHENYL)ETHANONE OXIME O (2 HYDROXY 3 PHENOXYPROPYL)ETHER; 1 (4 CHLOROPHENYL)ETHANONE OXIME O (2 HYDROXY 3 PHENOXYPROPYL)ETHER; 1 (4 CHLOROPHENYL)ETHANONE OXIME O (2 HYDROXYCYCLOHEXYL)ETHER; 1 (4 CHLOROPHENYL)ETHANONE OXIME O (3 BUTOXY 2 HYDROXYPROPYL)ETHER; 4 PHENYLBUTAN 2 ONE OXIME O (2 HYDROXY 3 PHENOXYPROPYL)ETHER; ACETOPHENONE OXIME O (2 HYDROXY 1 PHENYLETHYL)ETHER; ACETOPHENONE OXIME O (2 HYDROXY 2 PHENYLELTHYL)ETHER; ACETOPHENONE OXIME O (2 HYDROXY 3 PHENOXYPROPYL)ETHER; ACETOPHENONE OXIME O (2 HYDROXYCYCLOHEXYL)ETHER; ACETOPHENONE OXIME O (3 ALLYLOXY 2 HYDROXYPROPYL)ETHER; ACETOPHENONE OXIME O (3 BUTOXY 2 HYDROXYHEXYL)ETHER; ACETOPHENONE OXIME O (3 BUTOXY 2 HYDROXYPROPYL)ETHER; BENZOPHENONE OXIME O (2 HYDROXY 1 PHENYLETHYL)ETHER; BENZOPHENONE OXIME O (2 HYDROXY 2 PHENYLETHYL)ETHER; BENZOPHENONE OXIME O (2 HYDROXY 3 PHENOXYPROPYL)ETHER; BENZOPHENONE OXIME O (2 HYDROXYCYCLOHEXYL)ETHER; BENZOPHENONE OXIME O (2 HYDROXYOCTYL)ETHER; BENZOPHENONE OXIME O (2 HYDROXYPROPYL)ETHER; BENZOPHENONE OXIME O (3 ALLYLOXY 2 HYDROXYPROPYL)ETHER; BENZOPHENONE OXIME O (3 BUTOXY 2 HYDROXYPROPYL)ETHER; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA HYDROXY OXIME O ETHER DERIVATIVE; EPOXIDE; FLUOREN 9 ONE OXIME O (3 ALLYLOXY 2 HYDROXYPROPYL)ETHER; FLUOREN 9 ONE OXIME O (3 BUTOXY 2 HYDROXYPROPYL)ETHER; OXIME; POTASSIUM HYDROXIDE; PROPAN 2 ONE OXIME O (2 HYDROXY 1 PHENYLETHYL)ETHER; PROPAN 2 ONE OXIME O (2 HYDROXY 2 PHENYLETHYL)ETHER; PROPAN 2 ONE OXIME O (2 HYDROXY 3 PHENOXYPROPYL)ETHER;

ALKYLATION; AQUEOUS SOLUTION; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; EXPERIMENTATION; QUANTUM CHEMISTRY; RING OPENING; ROOM TEMPERATURE;

EID: 47349128343     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067122     Document Type: Article

References (75)

1. (a) March, J. Advanced Organic Chemistry, 4th ed.; John Wiley & Sons (Asia) Pte. Ltd.: Singapore, 2005.
2. (b) Kleeman, A.; Engel, J.; Kutscher, B.; Reichert, D. Pharmaceutical Substances, 3rd ed.; Thieme: Stuttgart, 1999.
3. (c) Kassa, J. Clin. Toxicol. 2002, 40, 803.
4. (d) Freeman, J. P. Chem. Rev. 1973, 73, 283.
5. (e) Gowenlock, B. G.; Richter-Addo, G. B. Chem. Rev. 2004, 104, 3315.
6. (a) Miyabe, H.; Ushiro, C.; Naito, T. Chem. Commun. 1997, 1789.
7. (b) Miyabe, H.; Fujii, K.; Naito, T. Org. Biomol. Chem. 2003, 1, 381.
8. (c)Miyabe, H.;Ueda,M.;Yoshiko,N.; Yamakawa, K.; Naito, T. Tetrahedron 2000, 56, 2413.
9. (d) Marco, J. A.; Carda, M.; Murga, J.; Conzàlez, F.; Falomir, E. Tetrahedron Lett. 1997, 38, 1841.
10. (a) Philipotts, R. J.; Delong, D. C.; Wallace, J.; Jones, R. W.; Reed, S. E.; Tyrrell, D. A. J. Lancet 1981, 1, 1342.
11. (b) Hayden, F. G.; Gawaltney, J. M. Jr. Antimicrob. Agents Chemother. 1982, 21, 892.
12. (c) Dewolfe Miller, F.; Monto, A. S.; Delong, D. C.; Exelby, A.; Bryan, E. R.; Srivastava, S. Antimicrob. Agents Chemother. 1985, 27, 102.
13. Sakene, K.; Kawabata, K.; Inamoto, Y.; Yamanaka, H.; Takaya, T. Yakugaku Zasshi 1993, 113, 605.
14. (a) Mixich, G.; Thiele, K. Arzneim.-Forsch. 1979, 29, 1510.
15. (b) Artico, M.; Rango, R.; Porretta, G. C.; Massa, S.; Musin, C.; Spiga, M. G.; Carrias, S.; La Colla, P. Med. Chem. Res. 1996, 137.
16. (c) Wihbi, Y.; Caujolle, R.; Tournaire, C.; Payard, M.; Linas, M. D.; Seguela, J. P. Eur. J. Med. Chem. 1995, 30, 955.
17. (a) Mordi, M. N.; Petta, M. D.; Boote, V.; Morris, G. A.; Barber, J. J. Med. Chem. 2000, 43, 467.
18. (b) Gharbi-Benarous, J.; Delaforge, M.; Jankowski, C. K.; Girault, J. P. J. Med. Chem. 1991, 34, 1117.
19. (a) De Clerk, F.; Beetens, J.; Van de Water, A.; Vercammen, E.; Janssen, P. A. J. Thromb. Haemostasis 1989, 61, 43.
20. (b) Bossche, H. V.; Willemsens, G.; Bellens, D.; Janssen, P. A. J. Biochem. Pharmacol. 1992, 43, 739.
21. (a) Abele, E.; Abele, R.; Rubina, K.; Popelis, J.; Sleiksa, I.; Lukevics, E. Synth. Commun. 1998, 28, 2621.
22. (b) Yamada, T.; Goto, K.; Mitsuda, Y.; Tsuji, J. Tetrahedron Lett. 1987, 28, 4557.
23. (c) Karakurt, A.; Dalkara, S.; Özalp, M.; Özbey, S.; Kendi, E.; Stables, J. P. Eur. J. Med. Chem. 2001, 36, 421.
24. (d) Merkaš, S.; Litvić, M.; Cepanec, I.; Vinković, V. Molecules 2005, 10, 1429.
25. (e) Abele, E.; Lukevics, E. Org. Prep. Proced. Int. 2000, 32, 237.
26. (f) Banerjee,T.;Dureja, P. Molecules 2005, 10, 990.
27. (g) Li, C. B.; Cui, Y.; Zhang, W. Q.; Li, J. L.; Zhang, S. M.; Choi, M. C. K.; Chan, A. S. C. Chin. Chem. Lett. 2002, 113, 95.
28. (a) Nanoppa, P. D.; Pandurangan, K.; Maitra, U.; Wailes, S. Org. Lett. 2007, 9, 2767.
29. (b) Mooradian, A.; Dupont, P. E. J. Heterocycl. Chem. 1967, 4, 441.
30. (a) Jacob, B. B. Synthesis 1975, 782.
31. (b) Nesynov, E. P. Zh. Org. Khim. 1976, 12, 1955.
32. Bittner, S.; Grinberg, S. J. Chem. Soc., Perkin Trans. 1 1976, 1708.
33. Stefani, A. P.; Lacher, J. R.; Park, J. D. J. Org. Chem. 1960, 25, 676.
34. Kolene, I.; Kocevar, M.; Polanc, S. Acta Chim. Slov. 1999, 46, 281.
35. (a) Miyabe, H.; Yoshida, K.; Reddy, V. K.; Matsumura, A.; Takemoto, Y. J. Org. Chem. 2005, 70, 5630.
36. (b) Miyabe, H.; Matsumura, A.; Yoshida, K.; Yamauchi, M.; Takemoto, Y. Synlett 2004, 2123.
37. (c) Miyabe, H.; Matsumura, A.; Moriyama, K.; Takemoto, Y. Org. Lett. 2004, 6, 4631.
38. (a) Bhuniya, D.; Mohan, S.; Narayanan, S. Synthesis 2003, 1018.
39. (b) Bertelsen, S.; Diner, P.; Johansen, R. L.; Jergensen, K. A. J. Am. Chem. Soc. 2007, 129, 1536.
40. (c) Vanderwal, C. D.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 14724.
41. (d) Fouchet, B.; Joucla, M.; Messager, J. C.; Toupet, L. J. Chem. Soc., Chem. Commun. 1982, 858.
42. (e) Bhuniya, D.; Gujjary, S.; Sengupta, S. Synth. Commun. 2006, 36, 151.
43. (a) Goda, H.; Sato, M.; Ihara, H.; Hirayama, C. Synthesis 1992, 849.
44. (b) Watson, K. G.; Brown, R. N.; Cameron, R.; Chalmers, D. K.; Hamilton, S.; Jin, B.; Krippner, G. Y.; Luttick, A.; McConnell, D. B.; Reece, P. A.; Ryan, J.; Stanislawski, P. C.; Tucker, S. P.; Wu, W.-Y.; Barnard, D. L.; Sidwell, R. W. J. Med. Chem. 2003, 46, 3181.
45. (c) Jahnson, S. M.; Petrassi, H. M.; Palaninathan, S. K.; Mohamedmohaideen, N. N.; Purkey, H. E.; Nichols, C.; Chiang, K. P.; Walkup, T.; Sacchettini, J. C.; Sharpless, K. B.; Kelly, J. W. J. Med. Chem. 2005, 48, 1576.
46. (d) Goda, H.; Ihara, H.; Hirayama, C.; Sato, M. Tetrahedron Lett. 1994, 35, 1565.
47. (a) Kliegel, W. Justus Liebigs Ann. Chem. 1970, 733, 192.
48. (b) Buchalska, E.; Plenkiewicz, J. J. Mol. Catal. B: Enzym. 2001, 11, 255.
49. (c) Bakunova, S. M.; Grigor'ev, I. A.; Volodarsky, L. B. Russ. Chem. Bull. 1999, 48, 1389.
50. (d) Sen, N.; Kar, Y.; Kurbanov, S. Russ. J. Org. Chem. (Engl. Transl.) 2007, 43, 449.
51. (a) Bouzoubaa, M.; Leclerc, G.; Decker, N.; Schwartz, J.; Andermann, G. J. Med. Chem. 1984, 27, 1291.
52. (b) Macchia, B.; Balsamo, A.; Lapucci, A.; Martinelli, A.; Macchia, F.; Brewhi, M. C.; Fantoni, B.; Martinotti, E. J. Med. Chem. 1985, 28, 153.
53. (c) Blanc, M.; Tamir, A.; Aubriot, S.; Michel, M. C.; Bouzoubaa, M.; Leclerc, G.; Demenge, P. J. Med. Chem. 1998, 41, 1613.
54. (a) Albrecht, U.; Gerwien, K.; Langer, P. Tetrahedron Lett. 2005, 46, 1017.
55. (b) Donald, J. R.; Edwards, M. G.; Taylor, R. J. K. Tetrahedron Lett. 2007, 48, 5201.
56. (c) Wan, X.; Doridot, G.; Joullié, M. M. Org. Lett. 2007, 9, 977.
57. (d) Koca, M.; Ahmedzade, M.; Çukurovali, A.; Kazaz, C. Molecules 2005, 10, 747.
58. Wilson, C. O.; Gisvold, O.; Block, J. H. Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 11th ed; Block, J. H.; Beale, J. M. Jr., Eds.; Lippincott Williams & Wilkins: Philadelphia, 2004.
59. (a) Nogrady, T.; Weaver, D. F. Medicinal Chemistry: A Molecular and Biochemical Approach, 3rd ed.; Oxford University Press: New York, 2005.
60. (b) Thomas, G. Medicinal Chemistry: An Introduction; John Wiley & Sons Ltd.: New York, 2000.
61. (c) Yuzhakov, S. D.; Glushkov, R. G.; Mashkovskii, M. D. Pharm. Chem. J. 1991, 25, 283.
62. (a) Leclerc, G.; Mann, A.; Wermuth, C. G. J. Med. Chem. 1977, 20, 1657.
63. (b) Mann, A.; Leclerc, G.; Wermuth, C. G.; Miesch, F.; Imbs, J. L.; Schwartz, J. A. Br. J. Pharmacol. 1977, 60, 357.
64. Grieco, P. A. Organic Synthesis in Water, Blackie Academic & Professional: London, 1998.
65. (a) Khalafi-Nezhad, A.; Soltani Rad, M. N.; Khoshnood, A. Synthesis 2003, 2552.
66. (b) Khalafi-Nezhad, A.; Soltani Rad, M. N.; Khoshnood, A. Synthesis 2004, 583.
67. Buck, J. S.; Ide, W. S. Org. Synth., Coll. Vol. 11 1943, 623.
68. Smith, P. A. S.; Robertson, J. E. J. Am. Chem. Soc. 1962, 84, 1197.
69. Buehler, E. J. Org. Chem. 1967, 32, 261.
70. Smith, S. G.; Milligan, D. V. J. Am. Chem. Soc. 1968, 90, 2393; and references cited therein.
71. Raczyńska, E. D.; Krygowski, T. M.; Zachara, J. E.; Osmialowski, B.; Gawinecki, R. J. Phys. Org. Chem. 2005, 18, 892.
72. The ab initio (6-31G) quantum mechanical calculations were run using Gaussian 98 Version 9.2 software. The semiempirical AM1 and PM3 calculations were run on MOP AC in CS Chem 3D Ultra 8 (CambridgeSoft, 2004) and Hyperchem (Hypercube Inc., Version 7).
73. Paul, J. H. US Patent 4158015, 1979; Chem. Abstr. 1979, 91, P107810v.
74. The separation of (E)- and (Z)-acetophenone oximes was achieved following a procedure in ref. 31.
75. Vogel, A. I. In Practical Organic Chemistry; Longmans, Green and Co.: London, 1954, Chap. II, 161-176.